The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Doctor at desk
Friday 19 January 2018
There has been a lot of coverage in the news today of a new test being developed in the United States that aims to detect eight different cancers (ovary, liver, stomach, pancreas, oesophagus, bowel, lung and breast) earlier.1 This test aims to combine checking for tumour DNA and certain types of...
News
Two nurses discuss treatment for their patient
Monday 18 December 2017
New ovarian cancer drug niraparib (Zejula ®), which was licensed for use in the UK by the European Medicines Agency last month, is part of a new class of ovarian cancer drugs called PARP inhibitors. Niraparib is yet to be approved for availability on the NHS; a decision is expected in the new year...
Blog
GP at his desk
Tuesday 12 December 2017
Nicola took part in a clinical trial after it was recommended by her oncologist. She has shared her experience with us. In November 2016 at the age of 30, following a laparotomy for removal of a suspected ovarian cyst, I was diagnosed with stage IIIC high grade endometrioid ovarian cancer. Now a...
News
In the lab with green gloves, a scientist in a white lab coat is working with chemicals
Wednesday 29 November 2017
Target Ovarian Cancer is proud to have committed over £1m to groundbreaking ovarian cancer research across the UK since the charity was founded in 2008. Today we announce our newest gold-standard research project at the University of Manchester. Professor Richard Edmondson and his team will look in...

Pages